Cargando…
MicroRNAs: Emerging Novel Clinical Biomarkers for Hepatocellular Carcinomas
The discovery of small non-coding RNAs known as microRNAs has refined our view of the complexity of gene expression regulation. In hepatocellular carcinoma (HCC), the fifth most frequent cancer and the third leading cause of cancer death worldwide, dysregulation of microRNAs has been implicated in a...
Autores principales: | Anwar, Sumadi Lukman, Lehmann, Ulrich |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4555081/ https://www.ncbi.nlm.nih.gov/pubmed/26295264 http://dx.doi.org/10.3390/jcm4081631 |
Ejemplares similares
-
The Emerging Role of MicroRNAs in Hepatocellular Carcinoma
por: Akkiz, Hikmet
Publicado: (2014) -
MicroRNAs as Biomarkers for Liver Disease and Hepatocellular Carcinoma
por: Hayes, C. Nelson, et al.
Publicado: (2016) -
LINE-1 hypomethylation in human hepatocellular carcinomas correlates with shorter overall survival and CIMP phenotype
por: Anwar, Sumadi Lukman, et al.
Publicado: (2019) -
Serum exosomal microRNAs as novel biomarkers for hepatocellular carcinoma
por: Sohn, Won, et al.
Publicado: (2015) -
Transposable Elements in Human Cancer: Causes and Consequences of Deregulation
por: Anwar, Sumadi Lukman, et al.
Publicado: (2017)